SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062207
Filing Date
2023-11-09
Accepted
2023-11-09 17:00:35
Documents
69
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q apto-20230930.htm   iXBRL 10-Q 1991087
2 EX-31.1 apto-ex31_1.htm EX-31.1 17169
3 EX-31.2 apto-ex31_2.htm EX-31.2 13656
4 EX-32.1 apto-ex32_1.htm EX-32.1 6930
5 EX-32.2 apto-ex32_2.htm EX-32.2 6916
6 GRAPHIC img238807848_0.jpg GRAPHIC 5225
  Complete submission text file 0000950170-23-062207.txt   7735734

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT apto-20230930_cal.xml EX-101.CAL 40795
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apto-20230930_def.xml EX-101.DEF 299719
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apto-20230930.xsd EX-101.SCH 53914
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apto-20230930_lab.xml EX-101.LAB 359993
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apto-20230930_pre.xml EX-101.PRE 366488
63 EXTRACTED XBRL INSTANCE DOCUMENT apto-20230930_htm.xml XML 1420425
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32001 | Film No.: 231393546
SIC: 2836 Biological Products, (No Diagnostic Substances)